Description

This document provides guidance on the study and analysis of sex differences in clinical trials of therapeutic products in order to generate evidence to advise on the optimal use of therapeutic products in both women and men.

Resources

Name	Format	Description	Link
Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/considerations-inclusion-women-clinical-trials.html
Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/produits-biologiques-radiopharmaceutiques-therapies-genetiques/information-demandes-presentations/lignes-directrices/considerations-relatives-inclusion-femmes-essais-cliniques-analyse.html

Tags

Topics

Categories